%20&%20Hidden%20Heart%20Risk.png)
The Health Pulse
🎙️ The Health Pulse – Your quick guide to better health!
In under 20 minutes, get expert insights on health and nutrition. Stay informed, and take charge of your wellness with actionable tips. Whether optimizing your health or exploring diagnostics, we keep it simple and insightful.
Listen, learn, and take control—one pulse at a time! 🔬✨
The Health Pulse
Episode 135 | The Heart Risk Your Cholesterol Test Misses
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
A “perfect” cholesterol test can still hide a dangerous cardiovascular trajectory. The 2026 ACC/AHA multisociety dyslipidemia guideline reflects a more complete way of evaluating risk—one that looks beyond LDL cholesterol alone.
In this episode of The Health Pulse, we explain why LDL-C measures the cholesterol carried inside lipoproteins but does not directly reveal how many atherogenic particles are circulating. Those particles can enter the artery wall, become trapped and modified, trigger inflammation, and contribute to plaque formation.
We break down ApoB as a practical measurement of atherogenic particle number and use a simple highway analogy to explain cholesterol discordance. This distinction is especially important for people with insulin resistance, metabolic syndrome, elevated triglycerides, fatty liver, or type 2 diabetes, whose LDL-C may appear reassuring even while ApoB remains elevated.
We also examine lipoprotein(a), or Lp(a), a largely inherited cardiovascular risk factor that may remain high despite a healthy lifestyle. You will learn why adults should generally have Lp(a) measured at least once, how an elevated result can influence risk assessment, and why it may justify testing close family members.
The conversation also covers the updated PREVENT cardiovascular risk equations, the return of clearer LDL-C treatment goals, when coronary artery calcium scanning can help resolve uncertainty, and how treatment may progress from lifestyle changes to statins, ezetimibe, PCSK9-targeting therapies, and other individualized options.
If you have ever been told your cholesterol is “normal,” this episode will help you understand what a basic lipid panel may still be missing—and which tests can provide a more complete picture of cardiovascular risk.
Subscribe to The Health Pulse for evidence-based conversations about metabolic health, laboratory testing, and disease prevention. Share this episode with someone who believes normal cholesterol automatically means low cardiovascular risk.
📞 Need lab work done from the comfort of home? QLM offers fast, reliable mobile phlebotomy services—no clinic visit required.
📅 Book your appointment or learn more at:
👉 Quick Lab Mobile
📧 Contact us: info@quicklabmobile.com
💬 Enjoyed the episode? Leave us a review and let us know what topics you'd like us to cover next! Your feedback helps us bring you the content that matters most.
Disclaimer: The information provided in this podcast is for informational purposes only and should not be considered medical advice. The content discussed is based on research, expert insights, and reputable sources, but it does not replace professional medical consultation, diagnosis, or treatment. We strive to present accurate and up-to-date information, medical research is constantly evolving. Listeners should always verify details with trusted health organizations, before making any health-related decisions. If you are experiencing a medical emergency, such as severe pain, difficulty breathing, or other urgent symptoms, call your local emergency services immediately. By listening to this podcast, you acknowledge that The Health Pulse and its creators are not responsible for any actions taken based on the content of this episode. Your health and well-being should always be guided by the advice of qualified medical professionals.
Welcome And The Big Promise
NicoletteWelcome to the Health Pulse, your go-to source for quick, actionable insights on health, wellness, and diagnostics. Whether you're looking to optimize your well-being or stay informed about the latest in-medical testing, we've got you covered. Join us as we break down key health topics in just minutes. Let's dive in.
Why LDL Alone Can Mislead
RachelYou know, you you could be a marathon runner with like single-digit body fat, a perfect diet, and have this absolutely flawless cholesterol test and still have a totally deadly genetic risk factor just quietly clogging your arteries.
MarkYeah, that's the terrifying part, really.
RachelAaron Powell It is. It is. Because for for decades, you know, whenever we talked about heart health, there was this very comforting, almost binary expectation of how it worked. Right. You've you go to the doctor, you fast for 12 hours, they draw your blood, and they look at your LDL. Trevor Burrus, Jr.
MarkThe so-called bad cholesterol. Trevor Burrus, Jr.
RachelRight, exactly. The bad cholesterol. And if the number is low, you get a gold star, and you just assume your arteries are squeaky clean. And if the number is high, you get a warning. It felt simple. It felt like basic plumbing, you know.
MarkAaron Ross Powell Yeah, the the plumbing analogy has been the cornerstone of how we've thought about this for for a really long time. Good cholesterol, bad cholesterol. And well, as long as the bad cholesterol mass was within the uh the laboratory reference range, the assumption was just that you were in the clear.
RachelAaron Powell But the medical community has realized that ABRA is just not the whole story. Trevor Burrus, Jr.
MarkNot at all.
RachelTrevor Burrus The the old good versus bad cholesterol binary is officially outdated.
MarkYeah, it's it's gone.
RachelAaron Powell Today we are throwing out that old rule book because we have this in-depth article from Quick Lab Mobile covering the brand new 2026 ACC AHA multi-society guidelines on the management of dyslipidemia.
MarkWhich is a huge deal.
RachelYeah, it's a completely new way of looking at heart disease. So our mission today is to bring you a simplified but highly actionable guide for navigating advanced lipid panel tests based on these new guidelines.
MarkAaron Powell And this really is a massive shift in preventive cardiology. The the guidelines move us away from this very basic volume estimate of cholesterol to a highly nuanced understanding of how lipids actually function, how they move through your bloodstream, and most importantly the specific biological mechanisms that actually
Lipoprotein Vehicles And Plaque Formation
Markcause disease.
RachelAaron Powell Okay, let's unpack this because dyslipidemia isn't just high cholesterol, is it?
MarkNo. I mean it's a it's a really complex disorder of lipid transport. So if cholesterol is fundamentally essential for our bodies, I mean we need it to build cell membranes.
RachelOh yeah, vitamin D synthesis. Trevor Burrus, Jr.
MarkRight. Vitamin D producing hormones like testosterone and estrogen. At what exact point does this vital substance become a killer?
RachelWell, see, cholesterol itself isn't the enemy. That's a huge misconception.
MarkOkay.
RachelThe core problem is entirely a matter of transportation.
MarkAaron Ross Powell Transportation.
RachelRight. Because cholesterol and triglycerides are fats. They're lipids.
MarkYeah.
RachelAnd blood is mostly water. So as we all know from you know trying to wash a greasy pan in the sink. Trevor Burrus, Jr.
MarkFat and water do not mix.
RachelExactly. They do not mix. So if your liver just dumped raw cholesterol into your bloodstream, it would clump up instantly. It would be a disaster. Wow. So the body has to pack these fat molecules into little microscopic vehicles called lipoproteins.
MarkAaron Ross Powell And that helps them navigate the watery environment of your blood. So the danger doesn't come from the cholesterol cargo itself. The danger comes from the actual vehicles getting trapped in the arterial wall.
RachelOh, I see. So these these microscopic vehicles are just cruising through our arteries, and sometimes they like pull off the road and get stuck in the subendothelial space. Trevor Burrus, Jr.
MarkThe inner lining of the artery. Yeah. That's the exact mechanism. When a vehicle gets stuck, it oxidizes.
RachelOkay.
MarkAnd your immune system spots it as foreign damage. So it sends macrophages, you know, white blood cells to clean it up. To swallow it up, yeah. But those cells gorge themselves on the trapped fat until they literally die.
NicoletteOh wow.
MarkYeah. They become what we call foam cells, which then build up to form a plaque. And that promotes localized inflammation and gradually narrows the artery. Trevor Burrus, Jr.
RachelSo if the root of the problem is the vehicles getting stuck in traffic and crashing into the arterial wall, we need to stop just looking at the cargo and start looking at the actual vehicles. And that brings us to the first major paradigm shift in the 2026 guidelines.
ApoB As A Particle Headcount
RachelAnd that is APOB.
MarkRight. Apoprotein B, or or APOB for short.
RachelWhat what exactly is that?
MarkSo it's a structural protein. Think of it like a structural belt that wraps around the outside of the lipoprotein vehicle to hold it together.
RachelOkay.
MarkNow here's the crucial part. Every single atherogenic particle.
RachelMeaning the ones that cause plaque.
MarkRight. Meaning every single particle that has the potential to crash into your arterial wall and cause plaque carries exactly one Apo B molecule on its surface.
RachelAaron Ross Powell One molecule per particle.
MarkJust one.
RachelWell, that makes the math wonderfully simple for testing.
MarkAaron Powell It does. What's fascinating here is that by measuring the concentration of APOB in the blood, we aren't just estimating the overall volume of cholesterol cargo anymore.
RachelBecause of that one-to-one ratio.
MarkExactly. We're doing a direct headcount of the danger particles. We're counting the actual vehicles circulating in your bloodstream.
RachelOkay, I want to make this really visual for everyone listening because the source has a great analogy and I kind of want to expand on it.
MarkGo for it.
RachelImagine you have two highways. Both highways need to transport the exact same amount of cargo. And let's let's say that cargo represents your standard LDL cholesterol mass.
MarkOkay, the standard lipid panel number.
RachelRight. So highway A uses a few massive, fully loaded 18-wheelers. Because the trucks are huge and completely packed with cargo, you only need a small number of them on the road to move the entire load.
MarkMakes sense.
RachelBut highway B uses thousands of tiny partially loaded pickup trucks to move that exact same amount of cargo.
MarkRight. And the total cholesterol cargo is identical on both highways.
RachelExactly identical. So if you only measure the cargo, which is what a standard LDLC test does, highway A and Highway B look identical, you get the exact same number on your blood test. But highway B is going to have way more traffic, way more congestion, and a much higher mathematical probability of those tiny pickup trucks crashing into the guardrails.
MarkAaron Powell Because there's just so many more of them.
RachelRight. So APO B counts the trucks, not the cargo.
MarkIt counts the trucks. And that discrepancy between the cargo mass and the sheer number of trucks is a physiological phenomenon we call discordance. Discordance. Right. And it happens constantly. It is actually a major reason why the 2026 guidelines push so heavily for APOB testing.
Discordance From Insulin Resistance
RachelAaron Powell But how does discordance actually happen biologically? I mean, why would someone's body choose to use thousands of tiny pickup trucks instead of just using the efficient 18 wheelers?
MarkWell, it often comes down to metabolic health, specifically insulin resistance.
RachelOkay.
MarkLet's look at how this plays out in a in a typical patient. Imagine someone comes into the clinic with an LDLC of 105 milligrams per deciliter.
RachelOkay.
MarkOn a standard lipid panel, that looks pretty normal.
RachelYeah, that's not bad.
MarkBut this patient is also dealing with elevated triglycerides, low HDL, and early insulin resistance. You know, maybe from a diet high in processed sugars and refined carbohydrates.
RachelWhich is a wildly common metabolic profile these days.
MarkExtremely common. So because of the insulin resistance, the body struggles to process energy properly. And the liver responds by pumping out an excess of triglyceride-rich particles called VLDL.
RachelVLDL. Okay.
MarkYeah. And as these extra particles circulate in the bloodstream, enzymes interact with them and they strip away the triglycerides.
RachelOkay.
MarkAnd through this kind of chaotic remodeling process in the blood, what you are left with are small, dense, cholesterol-depleted LDL particles.
RachelWait, they're depleted of cargo.
MarkRight. Because these individual particles now carry so little cholesterol, the liver has to manufacture and deploy a massive number of them just to transport the required baseline cargo around the body.
NicoletteOh, I see.
MarkSo this patient's LDLC mass looks totally normal, right? But their APOB, their actual particle head count, is secretly sky high.
NicoletteWow.
MarkYeah, their arteries are just being bombarded by a massive fleet of tiny pickup trucks.
RachelAaron Powell That is slightly terrifying, honestly. I mean, the standard test just gives you a false sense of security while the traffic jam is actively building up in your arteries.
MarkExactly.
RachelBut wait, what if we look at the reverse scenario?
MarkOkay.
RachelSay I'm metabolically healthy, maybe I'm doing a strict, very low carb keto diet, right? And my LDL cholesterol mass shoots up to a high level, but my APOB, my actual particle count, stays relatively low. Okay. Do I just ignore the high LDL? Like does one number magically cancel out the other?
MarkAaron Ross Powell The guidelines are clear that you don't just ignore it, but they provide crucial context. When LDLC and APOB disagree, when there is discordance, the clinical evidence generally indicates your cardiovascular risk aligns more closely with the APOB number. Okay. And that makes structural sense. Every physical particle is another opportunity to enter and become trapped in the arterial wall.
RachelSo the particle count is the ultimate predictor of actual physical crashes.
MarkIt is a superior predictor, yes. But an elevated LDLC in a healthy low-carb patient isn't automatically deemed entirely harmless.
RachelRight, right.
MarkCardiovascular risk is multifactorial. You have to view APOB holistically. Endothelial health matters. If your blood pressure is high or if you smoke, you are actively damaging the arterial wall. You're creating cracks in the guardrails to use your highway analogy.
RachelOh, I love that.
MarkAnd if the guardrails are damaged, well, even a low number of trucks can crash.
RachelYeah, that makes sense.
MarkSo the goal is to use APOB to clarify your specific biological risk, not to use it as an excuse to cherry pick which data points to care about.
RachelThat makes a lot of sense. So APOB helps us understand our metabolic risk based on our lifestyle, our insulin sensitivity, and our particle burden.
MarkCorrect.
Lp(a) The Genetic Risk Factor
RachelBut there is an entirely different risk factor floating in our blood that is completely invisible to standard tests. And honestly, it mostly ignores whether we eat salads or cheeseburgers.
MarkOh yes.
RachelLet's talk about the genetic ghost in our blood.
MarkAaron Powell You're referring to lipoprotein A or LPA.
RachelYes. From what I understand from the text, LPA is essentially an LDL particle that's wearing a dangerous disguise. Like it's an LDL particle that has this extra sticky protein attached to it, right?
MarkAaron Powell That's a great way to visualize it, yeah. It carries a standard APOB protein, just like a normal LDL particle.
RachelRight.
MarkBut it has an additional protein covalently bound to it called apolipoprotein A. Okay. And this unique structural modification makes LP a particularly destructive in a few different ways.
RachelAaron Ross Powell How so? Like what does that extra protein actually do to the body?
MarkAaron Powell Well, first, it makes the particle much stickier. So that means it gets trapped in the arterial wall more easily to promote plaque. Second, it acts as a carrier for oxidized phospholipids, which aggressively drive localized inflammation inside the artery.
RachelOkay, so it builds plaque and makes it angry.
MarkAaron Powell Exactly. And third, structurally, that extra protein looks very similar to a natural protein in your body called plasminogen.
RachelPlasminogen, what does that do?
MarkWell, normally plasminogen helps break down blood clots, but because LPA looks like plasminogen but doesn't function like it, it can actually interfere with your body's ability to dissolve clots, increasing your thrombosis risk.
RachelSo it builds the plaque, inflames the plaque, and then literally stops your body from clearing the clots if the plaque ruptures.
MarkYeah, it's a triple threat. And beyond the arteries, it is uniquely associated with the calcification of the aortic valve.
RachelWait, calcification?
MarkYeah, it binds to the cells in the valve and triggers biological pathways that cause those soft tissues to literally start developing bone-like calcifications.
RachelWow. And here's where it gets really interesting. Your LPAL levels are determined almost entirely by genetics. Entirely. So the marathon runner we talked about at the top of the show, who has single-digit body fat and eats perfectly, could still have deadly levels of LPS circulating in their system, completely unaffected by their lifestyle.
MarkThat is the hard truth. Unlike your standard LDL or even your APOB, which which can fluctuate based on your weight, your diet, your metabolic health, your LPAX concentration is genetically hardwired very early in life.
NicoletteWow.
MarkIt remains relatively stable throughout your entire adulthood. You cannot exercise it away. You cannot diet it away. And because it does not show up on a standard lipid panel, you could have a perfectly normal cholesterol test and be completely unaware of this significant inherited biological risk.
RachelAaron Powell Which brings us to the most aggressive mandate in the 2026 guidelines. They are fundamentally changing the rules on testing for this.
MarkAaron Powell They absolutely are. The 2026 guidelines mandate that every single adult needs to have their LP attested at least once in their lifetime.
RachelOnce in a lifetime.
MarkYes. Because historically, cardiologists only check this if a patient had a strong family history of early heart attacks. Trevor Burrus, Jr.
RachelRight. Like if your dad had a heart attack at 45.
MarkExactly. But the new recommendation recognizes that elevated LP LP is incredibly common. It affects roughly one in five people globally.
RachelAaron Powell One in five.
MarkOne in five. And it's mostly invisible. So if we don't test for it broadly, we leave millions of people exposed.
RachelAaron Ross Powell What are the specific thresholds we are looking at? Like when does this genetic ghost become an actionable threat?
MarkAaron Ross Powell Well the guidelines identify an LP, a concentration of 125 nanomoles per liter, which roughly translates to 50 milligrams per deciliter, depending on the specific laboratory assay as a formal risk-enhancing factor. It's a continuum. So the biological risk rises linearly as the number goes up.
RachelAaron Powell So the higher the number, the worse it is.
MarkYes. Levels above 125 nanomoles per liter are associated with a 1.4 times greater risk of cardiovascular disease.
RachelWow.
MarkAnd if you are above 250 nanomoles per liter, you're looking at at least double the baseline risk.
RachelOkay. I have a genuine concern here. As of 2026, the text says there's currently no approved FDA medication specifically designed just to lower LPA. That's right. I mean that there are dedicated therapies and clinical trials, but no simple LPA a pill on the market yet.
MarkNot yet.
RachelSo if it's purely genetic and I can't out-exercise it and I can't currently take a specific pill to fix it, what is the point of testing for it? Doesn't knowing I have a high number just give me lifelong anxiety without a solution.
MarkAaron Powell Well, I hear that a lot, but if we connect this to the bigger picture, knowing your LPA changes how aggressively you handle everything else that you can control.
RachelOh, okay. So it's about shifting the margins of risk elsewhere.
MarkExactly. Heart disease is a cumulative bucket of risk. If you know you have high LPA, your overall risk bucket is already partially full from the day you were born. That means you have zero room for error with the modifiable factors. Zero room. You and your clinician will become incredibly aggressive about keeping your APA B rock bottom. You will strictly manage your blood pressure to protect the arterial wall.
RachelRight.
MarkYou will relentlessly optimize your blood sugar. And you absolutely cannot smoke.
RachelSo the inherited genetic risk remains, but you completely change the metabolic environment surrounding it.
MarkRight. You're starving the disease of the additional kindling it needs to start a fire.
RachelOh, I like that. And because LPA is hardwired into your DNA, the danger doesn't stop with you.
MarkNo, it doesn't.
RachelIf your test comes back high, that immediately triggers a domino effect for your family, which doctors call cascade screening.
MarkAnd this is where the testing becomes profoundly life-saving. Yeah. If you discover you have elevated LPA, the immediate next medical step is to test your parents, your siblings, and your children.
RachelWow.
MarkYou might be the one individual who uncovers a hidden genetic risk running through your entire family tree.
RachelRight.
MarkAnd that allows them to get early interventions before a premature cardiac event occurs out of nowhere.
RachelAaron Powell So the knowledge isn't a burden. It's it's like a strategic advantage for your entire family line.
MarkAbsolutely.
RachelSo now that we understand the core mechanisms of APOP counting our atherogenic vehicles and LP uncovering our genetic risk, how does a patient actually use this in a modern clinic?
New Risk Tools And LDL Targets
RachelWhat is the the 2026 playbook?
MarkAaron Powell Okay. So the first major tool in the new playbook is the prevent ACVD equations.
RachelOkay. What is that?
MarkWell, in the past, doctors relied heavily on risk calculators that estimated your chance of a cardiovascular event over a 10-year window.
RachelRight.
MarkBut if you are 40 years old, a 10-year window is pretty narrow.
RachelAaron Powell Right. Because age is the heavily weighted factor in those old equations. So a 40-year-old's 10-year risk is almost always going to show up as low.
MarkExactly.
RachelSo they might just be told to keep doing what they're doing.
MarkAaron Ross Powell Right. And that's a missed opportunity for early prevention. So the prevent ACVD equations now calculate a 30-year risk window for adults aged 30 through 79.
RachelOh wow, 30 years.
MarkIt looks much further down the timeline.
RachelYeah.
MarkAnd crucially, it doesn't just look at age and cholesterol, it heavily factors in kidney function and metabolic health.
RachelSo a 40-year-old might have a low 10-year risk, meaning a doctor in 2020 would just say, you know, eat better and exercise. But a 30-year risk calculator might flag that same 40-year-old as having high lifetime risk. Yes. Meaning in 2026, they get put on life-saving preventative medication today, decades before the physical damage actually starts.
MarkAaron Powell That is the exact clinical intent. It allows for much earlier targeted intervention.
RachelAaron Powell And the guidelines also bring back hard targets for LDLC. Because for a while the medical guidance moved away from strict numeric goals, right?
MarkTrevor Burrus Yeah, they favor just prescribing a statin intensity. But the 2026 update establishes clear finish lines again, based on your risk category.
RachelAaron Powell What are those finish lines?
MarkFor adults at borderline or intermediate risk, the biological goal is generally to drive LDLC below 100 milligrams per deciliter.
RachelOkay, under 100.
MarkIf you are high risk, the target is below 70.
RachelUnder 70.
MarkAnd if you have established cardiovascular disease, meaning you've already had an event or severe plaque buildup, the goal is aggressively low, under 55 milligrams per deciliter.
RachelAaron Powell So what does this all mean for the person listening to us right now? We've explored all these advanced markers and biological mechanisms. Who actually needs to call their doctor tomorrow and say, I want an apopey test or I want an advanced lipid panel?
MarkAaron Powell Well, while the standard lipid panel remains the baseline starting point, there are clear prime candidates for advanced testing. Okay. First, anyone with type 2 diabetes, insulin resistance, or metabolic syndrome.
RachelBecause they have the discordance.
MarkExactly. Those are the patients actively experiencing that discordance where their liver is churning out a massive number of small depleted particles that a standard test completely misses.
RachelWow. Second would be anyone with triglycerides over 200 milligrams per deciliter, right?
MarkYes. Or anyone who has central abdominal obesity or fatty liver.
RachelOkay.
MarkAnd finally, people who have actually reached their LDLC goal on standard medication.
RachelWait, if they reach their goal, why do they need more testing?
MarkSay their LDL is perfectly under 70, but their doctor suspects there is still residual risk. Testing APOB can reveal if there are still simply too many particles circulating, despite the drug's effect on the total cholesterol mass.
RachelOh, because the the the the volume shrank, but the traffic jam is still there.
MarkExactly.
RachelGot it. And as we establish, every single adult needs the LPA test at least once.
MarkYes.
RachelBut here is the ultimate tiebreaker.
CAC Scan To Confirm Damage
RachelLet's say we do all these blood tests. We get the standard panel, we check the APOB headcount, we look at the LPA genetics. Okay. Blood tests only show us biological risk, right? Like our susceptibility to building plaque. And they don't actually tell us if the pipes are physically clogged yet.
MarkAaron Powell That is a vital clinical distinction. Blood markers estimate cumulative exposure. They tell us the biological conditions are ripe for atherosclerosis. But if a patient and a doctor are looking at all these lab numbers and they are still uncertain about whether to commit to a daily, lifelong medication like a statin.
RachelRight, which is a big decision.
MarkIt is. The guidelines heavily recommend a coronary artery calcium scan or a CAC scan.
RachelA CAC scan is essentially a specialized x-ray, right? It takes pictures of your heart to look for physical evidence of damage. But why are we looking for calcium?
MarkWell, when plaque forms in your arterial wall, the body treats it like an injury.
RachelOkay.
MarkAs a healing response, it attempts to stabilize that dangerous inflammatory plaque by depositing calcium into it.
RachelOh, to to harden it.
MarkEssentially turning it into a scar, yeah. So a CAC scan doesn't look at blood risk, it looks for that calcified scar tissue.
RachelSo if your blood tests show borderline risk, but your CAC stand comes back with a score of zero, meaning absolutely no calcified plaque is present.
MarkThe score of zero is a powerful negative predictor. In that scenario, you and your doctor might decide the physical damage hasn't started yet. And that allows you to hold off on medication and focus strictly on lifestyle interventions. Aaron Powell But if the scan shows established calcified plaque, then it confirms that the risk factors in your blood have already started causing structural damage to your arteries.
RachelRight.
MarkIt resolves the uncertainty immediately.
RachelIt's the difference between seeing a weather report that says it might rain and looking at the window to see if the street is already wet. That's exactly it. Let's briefly touch on how we treat all of this.
Treatment Options Beyond Lifestyle
RachelBecause advanced testing is only useful if we can alter the outcome.
MarkTrue.
RachelNutrition is still foundational. Lowering refined carbs and sugars directly improves insulin resistance, which stops the liver from overproducing trichos. Glycerides, which directly lowers your APO B particle count.
MarkTrevor Burrus, Jr.: Yeah, lifestyle modifies the biological environment. But when medication is necessary, statins remain the primary frontline treatment.
RachelRight.
MarkThey work by inhibiting an enzyme in the liver called HMG CoA reductase.
RachelWhich does what?
MarkIt effectively stops the liver from synthesizing its own cholesterol. When the liver can't make its own, it has to pull cholesterol out of the bloodstream. And that dramatically lowers your LDL and APOB levels.
RachelAaron Ross Powell But if statins aren't enough to hit those hard targets of under 70 or under 55, doctors aren't just out of options, are they?
MarkNo, no. There is an entire arsenal of secondary medications that work through completely different biological mechanisms.
RachelLike what?
MarkWell, if a statin doesn't get you to the finish line, doctors can prescribe ezotomy, which blocks the absorption of cholesterol in your gut.
RachelOkay.
MarkOr they can use a PCS canine inhibitor.
RachelHow does a PCS-K9 inhibitor work compared to a statin?
MarkInstead of just stopping cholesterol production, a PCS-K9 inhibitor works on the liver's receptors.
RachelReceptors, okay.
MarkThink of these receptors as loading docks that pull APOB vehicles off the highway.
RachelI like that.
MarkNormally a protein called PCSK9 destroys these loading docks after they are used. But the inhibitor blocks that protein.
RachelOkay.
MarkWhich allows your liver to build and recycle thousands of extra loading docks. And that rapidly pulls those dangerous APOB trucks out of your bloodstream.
RachelWow. That is incredibly cool. Okay, let's do a rapid-fire recap for everyone listening.
MarkLet's do it.
RachelThe standard lipid panel is still the foundation. It measures the total cholesterol cargo. Right. APOB is your advanced headcount. It counts the actual atherogenic vehicles capable of crashing into your arteries, and it is absolutely essential if you have any insulin resistance or metabolic issues. Absolutely. LPIA uncovers your hidden genetic risk, and every single adult needs it checked once.
MarkVery important.
RachelSo advanced testing isn't about getting a hundred tests and driving yourself crazy. It's about answering the specific, dangerous questions that your basic panel leaves blank.
MarkIt provides targeted clarity to prevent disease decades before it happens.
Genetics And Shared Family Prevention
RachelNow, as we wrap up, there is something that has been lingering in the background of this entire deep dive. Something heavily implied by the focus on LPIA and cascade screening.
MarkYeah. This raises an important question. We are entering an era where the sociology of cardiovascular health is fundamentally changing.
RachelThe sociology of it.
MarkRight. For decades, heart health was viewed purely as an individual journey.
RachelYeah, it was your diet, your treadmill time.
MarkExactly. Your personal lifestyle choices. Yeah. But if discovering your own elevated LP, a status immediately dictates the medical future of your children, your siblings, and your parents.
NicoletteWow.
MarkDoes knowing our genetic lipid profile shift heart disease from a personal health issue into a shared family responsibility?
RachelIf one blood test can rewrite the medical destiny of your entire family tree, maybe preventive cardiology isn't just self-care anymore. Right. Maybe it's the ultimate act of looking out for the people you love. Keep asking the right questions and don't be afraid to look beyond the basic panel. Catch you on the next deep dive.
NicoletteFor more health insights and diagnostics, visit us online at www.quicklabmobile.com. Stay informed, stay healthy, and we'll catch you in the next episode.
Podcasts we love
Check out these other fine podcasts recommended by us, not an algorithm.
